Thus, in the setting of insulin resistance in T2DM, the decreased insulin signaling and enhanced PARs activation may increase gastric tissue damage due to reduced PI3K/Akt activity and enhanced inflammatory responses. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.